Cellcolabs
PrivateLast Round
VC Round
Oct 27, 2025
Est. Valuation
$95.94M
Total Funding Raised
$28.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellcolabs is a biotechnology company that specializes in the industrial-scale, GMP-compliant production of high-quality Mesenchymal Stem Cells (MSCs) for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellcolabs Comparables
Compare Cellcolabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RoosterBio | 82% | |
| Histocell | 74% | |
| PromoCell GmbH | 69% |
Cellcolabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 27, 2025 | ||||
| Angel | Mar 5, 2024 | ||||
| VC Round | Mar 27, 2023 | ||||
| Series A | Mar 23, 2022 |
Key People
Founding team and executive leadership
Cellcolabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Takura | VC Round, Series A |
| Norrsken VC | Angel, Series A |
| Norrsken Launcher | Angel, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 203% MoM, reaching 4.3K.
- Jun 19, 2026
Technology built on over 25 years of research from Karolinska Institutet.
Cellcolabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellcolabs's valuation, stock price, and market status.
Is Cellcolabs a public or private company?
Cellcolabs is a private company.
What is the current stock price of Cellcolabs?
Cellcolabs is a private company with no public stock price. No recent secondary market data is available.
How much is Cellcolabs worth (valuation)?
Cellcolabs's valuation is estimated at $95.9M based on funding round data.
Can I buy Cellcolabs stock?
Cellcolabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cellcolabs's last funding round?
Cellcolabs's most recent funding round was Series A on October 27, 2025.
Who are the main investors in Cellcolabs?
Key investors in Cellcolabs include Norrsken VC.
Will Cellcolabs IPO soon?
No public IPO plans have been announced for Cellcolabs.
How can I track Cellcolabs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellcolabs's secondary market activity and sign up for updates.